Lab Manager | Run Your Lab Like a Business

Product News

New Platform Offers High-Throughput Single Cell Proteomics Analysis

The proteoCHIP™ EVO 96 was developed by Evosep in collaboration with Cellenion

The proteoCHIP™ EVO 96 on a white background

This innovative platform marks a major breakthrough in the field of single-cell proteomics, offering researchers unmatched capabilities and accuracy for studying cellular heterogeneity at the highest level.

by Evosep
Register for free to listen to this article
Listen with Speechify
0:00
5:00

Nordic Proteomics Symposium in Lund, Sweden, Evosep, a global leader in cutting-edge proteomics solutions, is thrilled with the introduction of the revolutionary proteoCHIP™ EVO 96, a product developed in collaboration with Cellenion. Recognizing an essential demand for robust and standardized solutions from the Single Cell Proteomics community, Evosep has joined forces with Cellenion, bridging technologies to unlock more standardized workflows.

This innovative platform marks a major breakthrough in the field of single-cell proteomics, offering researchers unmatched capabilities and accuracy for studying cellular heterogeneity at the highest level.

Single-cell proteomics is at the forefront of scientific exploration, allowing researchers to explore the intricacies of individual cells, providing insights into their functions, interactions, and potential implications in various diseases. The proteoCHIP EVO 96, a result of the partnership between Evosep and Cellenion, takes single-cell proteomics to an entirely new level.

Evosep's innovative technology allows for high-throughput, reproducible, and robust separation of peptides, delivering standardized analytical performance. Cellenion's unique single-cell isolation and dispensing platforms enable researchers to rapidly and reliably isolate single cells and dispense them into downstream assays.

The proteoCHIP EVO 96 combines Evosep's expertise in liquid chromatography technology with Cellenion's cutting-edge single-cell isolation and dispensing platforms. This synergy provides an all-encompassing solution that streamlines the process of single-cell proteomics, from the isolation of individual cells to in-depth data analysis.

Key Features of the proteoCHIP EVO 96:

  • High Throughput: The platform enables researchers to process up to 96 individual cells simultaneously, drastically increasing the efficiency of single-cell proteomic studies.
  • Precision Isolation: Cellenion's advanced technology ensures the precise isolation of individual cells, minimizing cross-contamination and preserving the integrity of each cell's proteomic content.
  • Enhanced Sensitivity: With Evosep's liquid chromatography, the ProteoCHIP Evo 96 offers unparalleled sensitivity and accuracy in identifying and quantifying proteins, even at low abundance.
  • Streamlined Workflow: The integrated solution simplifies the entire process, from cell isolation and sample preparation to data analysis, reducing the time and effort required for researchers to obtain meaningful results.

Nicolai Bache, VP Proteomics Research of Evosep, expressed their enthusiasm for the proteoCHIP EVO 96, saying, "Scaling single cell proteomics is now easier with the proteoCHIP EVO 96. It enables efficient direct transfer of digested single cells to Evotips, allowing reproducible, standardized, and scalable 96-sample processing, with secure sample storage until LC/MS analysis 96." 

Dr. Anjali Seth, Head of Single Cell Proteomics at Cellenion shared the sentiment, adding, "The proteoCHIP EVO 96 embodies our commitment to advancing single-cell proteomics. Our platform for isolation and Evosep's expertise in liquid chromatography combine seamlessly to empower researchers with a holistic solution for in-depth cellular analysis." 

The partnership between Evosep and Cellenion has set a new standard for single-cell proteomics, and the proteoCHIP EVO 96 is expected to catalyze breakthroughs in the understanding of cellular function and disease. This collaboration reflects both companies' dedication to pushing the boundaries of scientific research and improving diagnostics and therapeutics.